Injective (INJ) is holding above the critical $3.30 support level, signaling potential bullish momentum. Technical indicators show rising buying pressure, with the Relative Strength Index climbing to 63.68. Analysts project that if support holds, INJ could rally toward $6.40 in the short term, with an extended target near $15.40.
Injective (INJ) is trading at $3.38, up 1.82% over 24 hours and 12.51% over the last week. Its market capitalization stands at approximately $338 million, according to CoinMarketCap.
Crypto analyst LSTRADER highlighted that the asset is drawing attention as it hovers near the critical $3.30 support zone. “This level has previously triggered strong bullish reactions, making it a key area for traders watching potential accumulation,” the analyst stated.
The price has broken through the upper Bollinger Band, indicating a positive breakout from recent consolidation, according to data from TradingView. The RSI has moved up to 63.68, signaling increasing buying interest.
Analysts suggest that if the $3.30 support is maintained, the token could shift to a bullish growth trend. The initial target is set at $6.40, with a potential extended target near $15.40, based on market momentum.
